<DOC>
	<DOCNO>NCT01073111</DOCNO>
	<brief_summary>The purpose study compare coronary endothelium function patient zotarolimus-eluting versus sirolimus-eluting everolimus-eluting stent optical coherence tomography , vasoconstriction response acetylcholine , coronary biomarker level .</brief_summary>
	<brief_title>Assessment Stent Strut Coverage Endothelial Function After Drug-Eluting Stents</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Significant coronary de novo lesion ( &gt; 70 % quantitative angiographic analysis ) Patients stable acute coronary syndrome consider coronary revascularization Reference vessel diameter 2.5 3.5 mm operator assessment Contraindication antiplatelet agent Ostial lesion within 5 mm ostium Different DES vessel simultaneously Creatinine level 2.5 mg/dL Left main stenosis 50 % . vein graft lesion Triple vessel disease stenosis 50 % 3 epicardial coronary artery Life expectancy 1 year Reference vessel &lt; 2.5 mm &gt; 4.0 mm diameter visual Long lesion require three stent</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>